The clinical significance of circulating tissue factor in prostate cancer

Thrombosis and Haemostasis

Volumn 97, Issue 3, 2007, Pages 329-330

  Nieva, Jorge ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROCOAGULANT; CYSTEINE PROTEINASE; MEMBRANE PROTEIN; THROMBOPLASTIN;

ANGIOGENESIS; CANCER INVASION; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG TARGETING; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK PATIENT; HUMAN; METASTASIS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; TUMOR CELL; TUMOR GROWTH; VEIN THROMBOSIS;

BLOOD COAGULATION; CYSTEINE ENDOPEPTIDASES; HUMANS; MALE; NEOPLASM PROTEINS; PROGNOSIS; PROSTATIC NEOPLASMS; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33947302725     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-02-0104     Document Type: Editorial

References (12)

1. Langer F, Chun FKH, Amirkhosravi A, et al. Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers. Thromb Haemost 2007; 97: 464-470.
2. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985; 24: 5558-5567.
3. Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561-2568.
4. Broze GJ, Jr., Leykam JE, Schwartz BD, et al. Purification of human brain tissue factor. J Biol Chem 1985; 260: 10917-10920.
5. Morrissey JJH, Fakhrai HH, Edgington TTS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50: 129-135.
6. Harlos KK, Martin DDM, O'Brien DDP, et al. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-666.
7. Ruf W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 2006; 32 (Suppl 1): 61-68.
8. Ngo CV, Picha K, McCabe F, et al. CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int J Cancer 2007; 120: 1261-1267.
9. Altomare DDF, Rotelli MMT, Pentimone AA, et al. Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence. Colorectal Dis 2007; 9: 133-138.
10. Uno KK, Homma SS, Satoh TT, et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 2007; 96: 290-295.
11. Butenas S, Bouchard BA, Brummel-Ziedins KE, et al. Tissue factor activity in whole blood. Blood 2005; 105: 2764-2770.
12. Han LY, Landen CN, Jr., Kamat AA, et al. Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol 2006; 24: 755-761.